Results 71 to 80 of about 26,473 (159)

Medication-related challenges in patients living with an ostomy: Insights from a national cross-sectional exploratory survey. [PDF]

Explor Res Clin Soc Pharm
Hehenberger S, Glamočlija S, Lagoja I.
europepmc   +1 more source

Astaxanthin Delivery Across Administration Routes: Recent Advances to Improve Stability and Bioavailability. [PDF]

Pharmaceutics
Novelli L, Cespi M, Perinelli DR, Bonacucina G.   +3 more
europepmc   +1 more source

Extemporaneous Formulations for Pediatric Patients: Global Necessities, Challenges and Opportunities. [PDF]

Pharmaceutics
Pai VB, Nahata MC.
europepmc   +1 more source

Off-Label Manipulation of Paediatric Medication Remains a Challenge in Clinical Practice: An Observational Study. [PDF]

Acta Paediatr
Hamre Svendsen R, Andersen JKN, Kälvemark Sporrong S, Andersson Y, Tho I.   +4 more
europepmc   +1 more source

Colour of medicines and children's acceptability: What children think of the colour of oral dosage forms? [PDF]

Front Drug Deliv
Alessandrini E, Gizurarson S, Walsh J, Turner R, Schaufelberger D, Iurian S, Batchelor H, Klein S, Nafria B, Dicks P, Gaillard S, Franz AR, Albano J, Wisniewski A, Vermehren C, Gade C, Andersen JT, Tuleu C.   +17 more
europepmc   +1 more source

The need for patient-centric medicine design: investigating key physical characteristics of oral solid medications to improve acceptance of older patients in Addis Ababa, Ethiopia. [PDF]

PLoS One
Assefa MC, Paulos G, Ejeta F, Borga DK.
europepmc   +1 more source

Tablets before liquids? Rethinking paediatric prescribing in primary care. [PDF]

Br J Gen Pract
Elkhazragy A, Jonroy A, Payne RE.
europepmc   +1 more source

Development of a Taste-Masked, Dose-Flexible, Multiparticulate Pediatric Dosage Form: Case Study of Crizotinib, a Challenging Pediatric Formulation. [PDF]

Pharmaceut Med
Bartlett JA, Culver N, Santangelo M, Prpich A, Long E, Sagawa K, Shanker R, Xu H, Wilner K.   +8 more
europepmc   +1 more source

A Phase 1 Study to Assess the Relative Bioavailability of Brigatinib Administered as an Oral Solution Versus an Immediate-Release Tablet in Healthy Adults. [PDF]

Clin Pharmacol Drug Dev
Hanley MJ, Gounden R, Hupf B, Sarkar S, Fram RJ, Gupta N.   +5 more
europepmc   +1 more source